Epstein–Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age—A Pilot Study in Poland
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020711 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marek Mazurek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Masovian Cancer Hospital, 05-135 Wieliszew, Poland. Hauptthemen laut MEDLINE: Stomach Neoplasms, Herpesvirus 4, Human, Epstein-Barr Virus Infections, Papillomavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
Gastric cancer (GC) is one of the most common cancers in the world. It is a multi-factorial disease influenced by both genetic and environmental factors such as diet, obesity, radiation exposure, and infectious agents. Viral infections usually lead to chronic inflammation, which can initiate the development of cancers. To date, only a few studies have been published about Epstein–Barr virus (EBV) and human papillomavirus (HPV) infections in the context of the development of GC. In particular, research on the development of cancer among people under 45 years of age, including the impacts of EBV and HPV, is rare, and clear results have not been obtained. The aim of this study was to analyze the frequency of occurrence of EBV and HPV in GC, particularly in early-onset gastric cancer (EOGC). Tissue material from 135 patients with GC, including 84 men and 51 women, was examined. RT-PCR was performed to detect EBV, and PCR was performed to detect HPV. There were no significant impacts of EBV and HPV infections on any subtype of GC. There was also no statistically significant dependence of gender and location of the tumor on any subtype of GC. Further research on the impacts of infectious agents such as EBV and HPV on GC should be conducted using larger populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Masovian Cancer Hospital, 05-135 Wieliszew, Poland.
- Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-950 Lublin, Poland.
- Department of Conservative Dentistry with Endodontics, Medical University of Lublin, 20-090 Lublin, Poland.
- Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland.
- Independent Laboratory of Diagnostic, Interventional Endoscopy of the Department of Oncology, Medical University of Lublin, 20-081 Lublin, Poland.
- Department of Surgical Oncology, St. John's Cancer Center, 20-090 Lublin, Poland.
ORCID-Profile: Anna M Gliwa, Monika Z Sitarz, Ewa Dudzińska, Robert Sitarz
Förderung
- Medical University of Lublin
Zitieren
APA
Mazurek, M., Jaros, M., Gliwa, A. M., Sitarz, M. Z., Dudzińska, E., Zinkiewicz, K., & Sitarz, R. (2025). Epstein–Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age—A Pilot Study in Poland. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020711
Vancouver
Mazurek M, Jaros M, Gliwa AM, Sitarz MZ, Dudzińska E, Zinkiewicz K, et al. Epstein–Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age—A Pilot Study in Poland. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020711
BibTeX
@article{Mazurek2025,
author = {Mazurek, Marek and Jaros, Małgorzata and Gliwa, Anna M and Sitarz, Monika Z and Dudzińska, Ewa and Zinkiewicz, Krzysztof and Sitarz, Robert},
title = {Epstein–Barr Virus (EBV) and Human Papilloma Virus (HPV) in Gastric Cancers, with Special Reference to Gastric Cancer at a Young Age—A Pilot Study in Poland},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020711}
}
EUVIMED